{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T22:28:11Z","timestamp":1769552891993,"version":"3.49.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T00:00:00Z","timestamp":1694822400000},"content-version":"am","delay-in-days":319,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Government of Japan Ministry of Education Culture Sports Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.bcp.2022.115247","type":"journal-article","created":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T11:46:28Z","timestamp":1663069588000},"page":"115247","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Adenosine N6-methylation upregulates the expression of human CYP2B6 by altering the chromatin status"],"prefix":"10.1016","volume":"205","author":[{"given":"Motoki","family":"Isono","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masataka","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuki","family":"Fukami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miki","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7683","key":"10.1016\/j.bcp.2022.115247_b0005","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/nature24678","article-title":"Promoter-bound METTL3 maintains myeloid leukaemia by m6A-dependent translation control","volume":"552","author":"Barbieri","year":"2017","journal-title":"Nature"},{"issue":"23","key":"10.1016\/j.bcp.2022.115247_b0010","doi-asserted-by":"crossref","first-page":"13887","DOI":"10.1073\/pnas.95.23.13887","article-title":"c-Myc target gene specificity is determined by a post-DNA binding mechanism","volume":"95","author":"Boyd","year":"1998","journal-title":"PNAS"},{"issue":"3","key":"10.1016\/j.bcp.2022.115247_b0015","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/clpt.2010.127","article-title":"OPRM1 and CYP2B6 gene variants as risk factors in methadone-related deaths","volume":"88","author":"Bunten","year":"2010","journal-title":"Clin. Pharmacol. Ther."},{"issue":"6","key":"10.1016\/j.bcp.2022.115247_b0025","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1002\/hep.29683","article-title":"RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2","volume":"67","author":"Chen","year":"2018","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.bcp.2022.115247_b0030","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0163-7258(97)00089-2","article-title":"Biological effects of inhibitors of S-adenosylhomocysteine hydrolase","volume":"77","author":"Chiang","year":"1998","journal-title":"Pharmacol. Therapeut."},{"issue":"6","key":"10.1016\/j.bcp.2022.115247_b0035","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s40262-015-0257-3","article-title":"Central nervous system penetration of antiretroviral drugs: pharmacokinetic, pharmacodynamic and pharmacogenomic considerations","volume":"54","author":"Decloedt","year":"2015","journal-title":"Clin. Pharmacokinet."},{"issue":"7397","key":"10.1016\/j.bcp.2022.115247_b0040","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nature11112","article-title":"Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq","volume":"485","author":"Dominissini","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2022.115247_b0045","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/S0026-895X(24)12054-8","article-title":"Validation of bupropion hydroxylation as a selective marker of human cytochrome P450 2B6 catalytic activity","volume":"28","author":"Faucette","year":"2000","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bcp.2022.115247_b0050","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1038\/ncomms2822","article-title":"FTO-mediated formation of N6-hydroxymethyladenosine and N6-formyladenosine in mammalian RNA","volume":"4","author":"Fu","year":"2013","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.bcp.2022.115247_b0055","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00008571-199906000-00004","article-title":"Human CYP2B6: expression, inducibility and catalytic activities","volume":"9","author":"Gervot","year":"1999","journal-title":"Pharmacogenetics"},{"issue":"6","key":"10.1016\/j.bcp.2022.115247_b0060","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1101\/gr.5533506","article-title":"FAIRE (Formaldehyde-Assisted Isolation of Regulatory Elements) isolates active regulatory elements from human chromatin","volume":"17","author":"Giresi","year":"2007","journal-title":"Genome Res."},{"key":"10.1016\/j.bcp.2022.115247_b0070","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/S0026-895X(24)12046-9","article-title":"CYP2B6 mediates the in vitro hydroxylation of bupropion: Potential drug interactions with other antidepressants","volume":"28","author":"Hesse","year":"2000","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bcp.2022.115247_b0075","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1042\/bj3470321","article-title":"Regulation of cytochrome P450 (CYP) genes by nuclear receptors","volume":"347","author":"Honkakoski","year":"2000","journal-title":"Biochem. J."},{"issue":"8","key":"10.1016\/j.bcp.2022.115247_b0080","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0006-2952(99)00410-4","article-title":"Role of human liver microsomal CYP3A4 and CYP2B6 in catalyzing N-dechloroethylation of cyclophosphamide and ifosfamide","volume":"59","author":"Huang","year":"2000","journal-title":"Biochem. Pharmacol."},{"issue":"16","key":"10.1016\/j.bcp.2022.115247_b0085","doi-asserted-by":"crossref","first-page":"10425","DOI":"10.1074\/jbc.M800729200","article-title":"Nuclear receptor CAR requires early growth response 1 to activate the human cytochrome P450 2B6 gene","volume":"283","author":"Inoue","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.bcp.2022.115247_b0090","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/nchembio.687","article-title":"N6-Methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO","volume":"7","author":"Jia","year":"2011","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.bcp.2022.115247_b0095","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.bcp.2016.06.007","article-title":"MicroRNA hsa-miR-25-3p suppresses the expression and drug induction of CYP2B6 in human hepatocytes","volume":"113","author":"Jin","year":"2016","journal-title":"Biochem. Pharmacol."},{"issue":"19","key":"10.1016\/j.bcp.2022.115247_b0100","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1101\/gad.269415.115","article-title":"A majority of m6A residues are in the last exons, allowing the potential for 3\u2019 UTR regulation","volume":"29","author":"Ke","year":"2015","journal-title":"Genes Dev."},{"issue":"10","key":"10.1016\/j.bcp.2022.115247_b0105","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1261\/rna.064238.117","article-title":"The m6A reader protein YTHDC2 interacts with the small ribosomal subunit and the 5\u2019-3\u2019 exoribonuclease XRN1","volume":"24","author":"Kretschmer","year":"2018","journal-title":"RNA"},{"issue":"3","key":"10.1016\/j.bcp.2022.115247_b0110","first-page":"177","article-title":"Molecular mechanisms driving mRNA degradation by m6A modification","volume":"36","author":"Lee","year":"2020","journal-title":"Cell Press"},{"issue":"3","key":"10.1016\/j.bcp.2022.115247_b0115","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/cr.2017.10","article-title":"Cytoplasmic m6A reader YTHDF3 promotes mRNA translation","volume":"27","author":"Li","year":"2017","journal-title":"Cell Res."},{"issue":"9","key":"10.1016\/j.bcp.2022.115247_b0120","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/s41588-020-0677-3","article-title":"N6-Methyladenosine co-transcriptionally directs the demethylation of histone H3K9me2","volume":"52","author":"Li","year":"2020","journal-title":"Nat. Genet."},{"issue":"2","key":"10.1016\/j.bcp.2022.115247_b0125","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nchembio.1432","article-title":"A METTL3-METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation","volume":"10","author":"Liu","year":"2014","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.bcp.2022.115247_b0130","doi-asserted-by":"crossref","first-page":"5332","DOI":"10.1038\/s41467-019-13317-9","article-title":"m6A in mRNA coding regions promotes translation via the RNA helicase-containing YTHDC2","volume":"10","author":"Mao","year":"2019","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.bcp.2022.115247_b0135","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/j.cell.2012.05.003","article-title":"Comprehensive analysis of mRNA methylation reveals enrichment in 3\u2019 UTRs and near stop codons","volume":"149","author":"Meyer","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2022.115247_b0140","doi-asserted-by":"crossref","first-page":"100388","DOI":"10.1016\/j.dmpk.2021.100388","article-title":"Identification of miRNAs that regulate human CYP2B6 expression","volume":"38","author":"Nakano","year":"2021","journal-title":"Drug Metab. Pharmacokinet."},{"issue":"5","key":"10.1016\/j.bcp.2022.115247_b0150","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1124\/dmd.121.000390","article-title":"Adenosine-to-Inosine RNA editing and N6-methyladenosine modification modulating expression of drug metabolizing enzymes","volume":"50","author":"Nakano","year":"2022","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bcp.2022.115247_b0155","doi-asserted-by":"crossref","first-page":"113697","DOI":"10.1016\/j.bcp.2019.113697","article-title":"Methylation of adenosine at the N6 position post-transcriptionally regulates hepatic P450s expression","volume":"171","author":"Nakano","year":"2020","journal-title":"Biochem. Pharmacol."},{"issue":"6","key":"10.1016\/j.bcp.2022.115247_b0160","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1124\/dmd.119.086702","article-title":"RNA editing enzymes modulate the expression of hepatic CYP2B6, CYP2C8, and other cytochrome P450 isoforms","volume":"47","author":"Nozaki","year":"2019","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bcp.2022.115247_b0165","doi-asserted-by":"crossref","first-page":"114402","DOI":"10.1016\/j.bcp.2020.114402","article-title":"The N6-methyladenosine modification posttranscriptionally regulates hepatic UGT2B7 expression","volume":"189","author":"Ondo","year":"2021","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.bcp.2022.115247_b0170","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.tiv.2009.09.025","article-title":"Involvement of pregnane X receptor in the regulation of CYP2B6 gene expression by oltipraz in human hepatocytes","volume":"24","author":"Piton","year":"2010","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.bcp.2022.115247_b0175","doi-asserted-by":"crossref","unstructured":"Roundtree IA, Luo GZ, Zhang Z, Wang X, Zhou T, Cui Y, Sha J, Huang X, Guerrero L, Xie P, He E, Shen B, and He C (2017) YTHDC1 mediates nuclear export of N6-methyladenosine methylated mRNAs. Elife 6: e31311.","DOI":"10.7554\/eLife.31311"},{"issue":"3","key":"10.1016\/j.bcp.2022.115247_b0180","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/cr.2017.15","article-title":"YTHDF3 facilitates translation and decay of N6-methyladenosine-modified RNA","volume":"27","author":"Shi","year":"2017","journal-title":"Cell Res."},{"issue":"16","key":"10.1016\/j.bcp.2022.115247_b0185","doi-asserted-by":"crossref","first-page":"12822","DOI":"10.1074\/jbc.M005930200","article-title":"Orphan receptor promiscuity in the induction of cytochromes p450 by xenobiotics","volume":"276","author":"Smirlis","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"47","key":"10.1016\/j.bcp.2022.115247_b0190","doi-asserted-by":"crossref","first-page":"49307","DOI":"10.1074\/jbc.M407281200","article-title":"Cytoplasmic localization of pregnane X receptor and ligand-dependent nuclear translocation in mouse liver","volume":"279","author":"Squires","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2022.115247_b0195","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1158\/0008-5472.CAN-04-0166","article-title":"Human CYP1B1 is regulated by estradiol via estrogen receptor","volume":"64","author":"Tsuchiya","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2022.115247_b0205","doi-asserted-by":"crossref","first-page":"598","DOI":"10.2174\/138920008785821710","article-title":"CYP2B6: New insights into a historically overlooked cytochrome P450 isozyme","volume":"9","author":"Wang","year":"2008","journal-title":"Curr. Drug Metab."},{"issue":"7481","key":"10.1016\/j.bcp.2022.115247_b0210","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nature12730","article-title":"N6-methyladenosine-dependent regulation of messenger RNA stability","volume":"505","author":"Wang","year":"2014","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.bcp.2022.115247_b0215","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.cell.2015.05.014","article-title":"N6-Methyladenosine modulates messenger RNA translation efficiency","volume":"161","author":"Wang","year":"2015","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bcp.2022.115247_b0220","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1124\/jpet.103.049601","article-title":"The cytochrome P450 2B6 (CYP2B6) is the main catalyst of efavirenz primary and secondary metabolism: Implication for HIV\/AIDS therapy and utility of efavirenz as a substrate marker of CYP2B6 catalytic activity","volume":"306","author":"Ward","year":"2003","journal-title":"JPET"},{"issue":"4","key":"10.1016\/j.bcp.2022.115247_b0225","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.molcel.2016.01.012","article-title":"Nuclear m(6)A reader YTHDC1 regulates mRNA splicing","volume":"61","author":"Xiao","year":"2016","journal-title":"Mol. Cell"},{"issue":"1","key":"10.1016\/j.bcp.2022.115247_b0230","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.bbrc.2019.08.018","article-title":"METTL3 inhibits hepatic insulin sensitivity via N6-methyladenosine modification of Fasn mRNA and promoting fatty acid metabolism","volume":"518","author":"Xie","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"7","key":"10.1016\/j.bcp.2022.115247_b0235","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/j.cell.2020.05.012","article-title":"A unified model for the function of YTHDF proteins in regulating m6A-modified mRNA","volume":"181","author":"Zaccara","year":"2020","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bcp.2022.115247_b0240","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.pharmthera.2012.12.007","article-title":"Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation","volume":"138","author":"Zanger","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bcp.2022.115247_b0245","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3389\/fgene.2013.00024","article-title":"Pharmacogenetics of cytochrome P450 2B6 (CYP2B6): advances on polymorphisms, mechanisms, and clinical relevance","volume":"4","author":"Zanger","year":"2013","journal-title":"Front. Genet."},{"key":"10.1016\/j.bcp.2022.115247_b0250","doi-asserted-by":"crossref","first-page":"28116","DOI":"10.1038\/srep28116","article-title":"Antiproliferation of berberine is mediated by epigenetic modification of constitutive androstane receptor (CAR) metabolic pathway in hepatoma cells","volume":"6","author":"Zhang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2022.115247_b0255","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.molcel.2012.10.015","article-title":"ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fertility","volume":"49","author":"Zheng","year":"2013","journal-title":"Mol. Cell"},{"issue":"6","key":"10.1016\/j.bcp.2022.115247_b0260","doi-asserted-by":"crossref","first-page":"915","DOI":"10.4161\/rna.24711","article-title":"Sprouts of RNA epigenetics: the discovery of mammalian RNA demethylases","volume":"10","author":"Zheng","year":"2013","journal-title":"RNA Biol."},{"key":"10.1016\/j.bcp.2022.115247_b0265","doi-asserted-by":"crossref","first-page":"25677","DOI":"10.1038\/srep25677","article-title":"N6-Methyladenosine: a conformational marker that regulates the substrate specificity of human demethylases FTO and ALKBH5","volume":"6","author":"Zou","year":"2016","journal-title":"Sci. Rep."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295222003410?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295222003410?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:36:00Z","timestamp":1757770560000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295222003410"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":49,"alternative-id":["S0006295222003410"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2022.115247","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adenosine N6-methylation upregulates the expression of human CYP2B6 by altering the chromatin status","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2022.115247","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115247"}}